Valuation check: BIOYF's profit margin is 17.73%, above the sector sector average of 13.23%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for BIOYF is 17.73% as of June 2026. That compares with 20.9% in the prior-year period — down 15.2% year over year. That is above the sector sector average of 13.23%. Investors often review this figure alongside BioSyent's historical trend and sector peers before judging valuation or financial health.
Over the past year, BIOYF's profit margin moved from 20.9% to 17.73% — a 15.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioSyent's valuation or profitability profile.
Against its sector companies, BIOYF currently prints 17.73% for profit margin, while the sector average sits near 13.23%. That is roughly 34.0% above the sector mean. Large gaps often invite a closer look at BioSyent's growth, margins, and balance sheet.
Profit Margin shows how effectively BioSyent converts resources into returns. At 17.73%, BIOYF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 20.9% in the prior-year period — down 15.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BIOYF's profit margin (17.73%), review year-over-year change from 20.9%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.